Komori
itsumo. (7694) · TargetDisclosure of results for the target fiscal year

Revenue and Adjusted EBITDA Targets for the Fiscal Year Ending March 2025

First written in FY2023-Q2. 1 of 3 entries say "Restated". Latest entry: FY2025.

3entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q2 – FY20252022: 120222023: 020232024: 120242025: 12025
Same theme, other companies
Stock acquisition rights with combined EBITDA and revenue conditionsA theme 4 companies write about · 0 as a headwind · 4 as a tailwind

0 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2025Disclosure of results for the target fiscal yearAnnual report

    「As a result, revenue for the fiscal year was ¥13,940.858 million, up 0.6% year on year; operating income was ¥74.434 million, down 76.8%; ordinary income was ¥43.447 million, down 85.6%; and the net loss attributable to owners of the parent was ¥98.093 million, compared with net income attributable to owners of the parent of ¥258.961 million in the previous fiscal year.」

    It discloses the results for the fiscal year ending March 2025 against the new share acquisition rights exercise conditions based on revenue of ¥30,000 million and adjusted EBITDA of ¥2,630 million.
  2. FY2024-Q3RestatedAnnual report

    「(a) If revenue for the fiscal year ending March 2025 exceeds ¥30,000 million or adjusted EBITDA exceeds ¥2,630 million Exercisable Percentage: 1/2 (b) If revenue for the fiscal year ending March 2025 exceeds ¥30,000 million and adjusted EBITDA exceeds ¥2,630 million Exercisable Percentage: 2/2」

    The fifth series of new share acquisition rights also includes exercise conditions based on revenue of ¥30,000 million and adjusted EBITDA of ¥2,630 million for the fiscal year ending March 2025, indicating that the targets remain in place.
  3. FY2023-Q2First statedAnnual report

    「(a) If revenue for the fiscal year ending March 2025 exceeds ¥30,000 million or adjusted EBITDA exceeds ¥2,630 million Exercisable Percentage: 1/2 (b) If revenue for the fiscal year ending March 2025 exceeds ¥30,000 million and adjusted EBITDA exceeds ¥2,630 million Exercisable Percentage: 2/2」

    It discloses for the first time specific exercise conditions for the fourth series of new share acquisition rights, requiring revenue of ¥30,000 million and adjusted EBITDA of ¥2,630 million for the fiscal year ending March 2025. If only one target is exceeded, 1/2 of the rights may be exercised; if both are exceeded, all rights may be exercised.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for itsumo. yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.